A Double‐Blind Randomized Study of Two Doses of Oral Isotretinoin in the Treatment of Recalcitrant Facial Flat Warts: Impact on Quality of Life, Anxiety, and Depression
ABSTRACT Background and Aims Recalcitrant facial flat warts are caused by human papillomavirus and may persist for years despite treatment. Oral isotretinoin administered at a dose of 0.5 mg/kg/day is effective and safe. However, the adverse effects reported are dose‐dependent behaviors and they cou...
Saved in:
| Main Authors: | María Guadalupe Olguín‐García, María Luisa Peralta‐Pedrero, Martha Alejandra Morales‐Sánchez, Elisa Vega‐Memije, Víctor Manuel Bautista‐de Lucio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Health Science Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/hsr2.70684 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topical 5-aminolevulinic acid photodynamic therapy for recalcitrant facial flat warts
by: Weiming Zhang, et al.
Published: (2024-02-01) -
Application of photodynamic therapy with 5-aminolevulinic acid and fractional CO2 laser for the management of recalcitrant plantar warts
by: Jiaoquan Chen, et al.
Published: (2025-02-01) -
Photodynamic Therapy Combined with Liquid Nitrogen Cryotherapy and Curettage for the Treatment of Recalcitrant Periungual and Subungual Warts: Clinical Experience and Literature Review
by: Kuixia Xie, et al.
Published: (2024-01-01) -
Oral isotretinoin for the treatment of dermatologic conditions other than acne: a case series
by: Abdulrahman Janahi, et al.
Published: (2025-08-01) -
Assessment of peripheral blood toll-like receptor 2 expression and vitamin D serum level as predictors of response to intralesional vitamin D in the treatment of warts
by: Eman M. K. Sanad, et al.
Published: (2024-05-01)